Dermatomyositis

Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO

Environmental Risk Factors for Myositis in Military Personnel

Studies of the Natural History and Pathogenesis of Autoimmune/Connective Tissue Diseases

A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy.

RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy

A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy

Subcutaneous Injection of Sodium Thiosulfate for Ectopic Calcifications or Ossifications. A Pilot Study

A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis

Adult and Juvenile Myositis

Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study

Identification of Cutaneous and Blood Biomarkers Predictive of Response to Systemic Treatments During Chronic Inflammatory Skin Diseases

Environmental Risk Factors for the Anti-synthetase Syndrome

Baricitinib in Patients With Relapsing or naïve Dermatomyositis

Teams Engaged in Accessible Mental Health Interventions for Lupus Erythematosus and Dermatomyositis Stress

A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies

A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With Dermatomyositis

Biomarkers of Cancer-Associated Myositis

Intralesional Injection of STS in Treatment of Calcinosis

Exploratory Clinical Study of Anti-CD19/BCMA Universal CAR-T Cell Injection for the Treatment of Refractory Autoimmune Diseases

Diagnostic Accuracy of Whole Body Magnetic Resonance Imaging in Inflammatory Myopathies